journal article·2024-01Open access

LncRNAs‐circRNAs as Rising Epigenetic Binary Superstars in Regulating Lipid Metabolic Reprogramming of Cancers

Shanshan Liu, Benzheng Jiao, Hongguang Zhao, Xinyue Liang, Fengyan Jin, Xiaodong Liu, Ji‐Fan Hu

Advanced Science· Volume 11· Issue 1

Abstract

Abstract As one of novel hallmarks of cancer, lipid metabolic reprogramming has recently been becoming fascinating and widely studied. Lipid metabolic reprogramming in cancer is shown to support carcinogenesis, progression, distal metastasis, and chemotherapy resistance by generating ATP, biosynthesizing macromolecules, and maintaining appropriate redox status. Notably, increasing evidence confirms that lipid metabolic reprogramming is under the control of dysregulated non‐coding RNAs in cancer, especially lncRNAs and circRNAs. This review highlights the present research findings on the aberrantly expressed lncRNAs and circRNAs involved in the lipid metabolic reprogramming of cancer. Emphasis is placed on their regulatory targets in lipid metabolic reprogramming and associated mechanisms, including the clinical relevance in cancer through lipid metabolism modulation. Such insights will be pivotal in identifying new theranostic targets and treatment strategies for cancer patients afflicted with lipid metabolic reprogramming.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: Cancer, Lipids, and Metabolism · Cancer, Hypoxia, and Metabolism · Cancer-related molecular mechanisms research

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Key Laboratory of Organ Regeneration and Transplantation of Ministry of Education Cancer Center, First Hospital Jilin University Changchun 130021 China

Hematology Department First Hospital Jilin University Changchun 130021 China

NHC Key Laboratory of Radiobiology (Jilin University) School of Public Health Jilin University Changchun 130021 China

Nuclear Medicine Department First Hospital Jilin University Changchun 130021 China

Radiation Medicine Department, School of Public Health and Management Wenzhou Medical University Wenzhou 325035 China

Palo Alto Veterans Institute for Research Stanford University Medical School Palo Alto CA 94304 USA

Funding

National Key Research and Development Program of China · National Natural Science Foundation of China · California Institute of Regenerative Medicine · Natural Science Foundation of Jilin Province

References (100+)

Show source-provided references
1. 10.1016/j.cell.2011.02.01310.1016/j.cell.2011.02.013 ↗
2. 10.1038/nrc.2016.7710.1038/nrc.2016.77 ↗
3. 10.1016/j.cmet.2015.12.00610.1016/j.cmet.2015.12.006 ↗
4. 10.1016/j.trecan.2017.01.00510.1016/j.trecan.2017.01.005 ↗
5. 10.1038/s41568-021-00388-410.1038/s41568-021-00388-4 ↗
6. 10.1038/s41573-021-00339-610.1038/s41573-021-00339-6 ↗
7. 10.1186/s13045-018-0648-710.1186/s13045-018-0648-7 ↗
8. 10.1007/s00018-018-2946-110.1007/s00018-018-2946-1 ↗
9. 10.1016/j.ymthe.2021.03.01710.1016/j.ymthe.2021.03.017 ↗
10. 10.7150/ijbs.4076910.7150/ijbs.40769 ↗
11. 10.3390/cancers1401001310.3390/cancers14010013 ↗
12. 10.1186/s13045-019-0776-810.1186/s13045-019-0776-8 ↗
13. 10.1186/s12929-017-0358-410.1186/s12929-017-0358-4 ↗
14. 10.1016/j.canlet.2020.10.00210.1016/j.canlet.2020.10.002 ↗
15. 10.1186/s12943-017-0699-310.1186/s12943-017-0699-3 ↗
16. 10.3390/cancers1401001310.3390/cancers14010013 ↗
17. 10.1007/s10555-021-09996-w10.1007/s10555-021-09996-w ↗
18. 10.3390/cancers1301001210.3390/cancers13010012 ↗
19. 10.1016/j.cmet.2019.11.01010.1016/j.cmet.2019.11.010 ↗
20. 10.1038/s41416-019-0451-410.1038/s41416-019-0451-4 ↗
21. 10.1016/j.addr.2020.07.01310.1016/j.addr.2020.07.013 ↗
22. 10.1016/j.cmet.2013.05.01710.1016/j.cmet.2013.05.017 ↗
23. 10.1186/s12885-019-5733-y10.1186/s12885-019-5733-y ↗
24. 10.1016/j.molmed.2017.02.00910.1016/j.molmed.2017.02.009 ↗
25. 10.1371/journal.pone.010691310.1371/journal.pone.0106913 ↗
26. 10.1016/j.juro.2013.06.05010.1016/j.juro.2013.06.050 ↗
27. 10.1016/j.molcel.2016.02.00910.1016/j.molcel.2016.02.009 ↗
28. 10.1038/nature1060210.1038/nature10602 ↗
29. 10.1002/hep.2841510.1002/hep.28415 ↗
30. 10.2174/15748921279997291810.2174/157489212799972918 ↗
31. 10.3390/ijms15071153910.3390/ijms150711539 ↗
32. 10.3892/or.2014.348410.3892/or.2014.3484 ↗
33. 10.1038/nrc222210.1038/nrc2222 ↗
34. 10.1038/nm166210.1038/nm1662 ↗
35. 10.1016/S0163-7827(03)00039-010.1016/S0163-7827(03)00039-0 ↗
36. 10.1084/jem.2020160610.1084/jem.20201606 ↗
37. 10.1016/j.jhep.2017.06.01510.1016/j.jhep.2017.06.015 ↗
38. 10.7150/jca.3859810.7150/jca.38598 ↗
39. 10.1074/jbc.RA118.00444210.1074/jbc.RA118.004442 ↗
40. 10.1016/j.canlet.2018.03.03410.1016/j.canlet.2018.03.034 ↗
41. 10.1038/srep1943510.1038/srep19435 ↗
42. 10.1016/j.bbcan.2020.18835110.1016/j.bbcan.2020.188351 ↗
43. 10.1038/nrm.2016.6710.1038/nrm.2016.67 ↗
44. 10.1038/nrc.2016.7610.1038/nrc.2016.76 ↗
45. 10.1038/s41416-019-0650-z10.1038/s41416-019-0650-z ↗
46. 10.1155/2018/780120210.1155/2018/7801202 ↗
47. 10.1016/j.bbalip.2011.09.01010.1016/j.bbalip.2011.09.010 ↗
48. Go G. W. · Yale J. Biol. Med. · 2012 · 85 · 19
49. 10.3892/or.2017.586410.3892/or.2017.5864 ↗
50. 10.1038/nature2079110.1038/nature20791 ↗
51. 10.1038/srep1475210.1038/srep14752 ↗
52. 10.1158/2159-8290.CD-11-010210.1158/2159-8290.CD-11-0102 ↗
53. 10.1038/nrc348310.1038/nrc3483 ↗
54. 10.1097/MCO.000000000000038110.1097/MCO.0000000000000381 ↗
55. 10.1016/j.celrep.2016.07.00910.1016/j.celrep.2016.07.009 ↗
56. Wang J. · Am. J. Cancer Res. · 2021 · 11 · 2477
57. 10.1038/s41419-018-0313-710.1038/s41419-018-0313-7 ↗
58. 10.1016/j.bbcan.2020.18839410.1016/j.bbcan.2020.188394 ↗
59. 10.1038/s41580-019-0190-710.1038/s41580-019-0190-7 ↗
60. 10.1038/s42255-020-0174-010.1038/s42255-020-0174-0 ↗
61. 10.1016/j.semcancer.2019.10.00410.1016/j.semcancer.2019.10.004 ↗
62. 10.1038/nrc391210.1038/nrc3912 ↗
63. 10.3390/molecules2801002710.3390/molecules28010027 ↗
64. 10.1038/s41580-018-0085-z10.1038/s41580-018-0085-z ↗
65. 10.1007/s11745-017-4263-010.1007/s11745-017-4263-0 ↗
66. 10.1016/j.jbior.2018.12.00110.1016/j.jbior.2018.12.001 ↗
67. 10.1158/1078-0432.CCR-15-297310.1158/1078-0432.CCR-15-2973 ↗
68. 10.1016/j.cmet.2014.01.01910.1016/j.cmet.2014.01.019 ↗
69. 10.1016/j.plipres.2021.10114310.1016/j.plipres.2021.101143 ↗
70. 10.1038/s41419-018-0345-z10.1038/s41419-018-0345-z ↗
71. 10.7150/ijbs.7490210.7150/ijbs.74902 ↗
72. 10.1172/jci.insight.8748910.1172/jci.insight.87489 ↗
73. 10.1016/j.cmet.2012.09.00210.1016/j.cmet.2012.09.002 ↗
74. 10.1172/JCI021559310.1172/JCI0215593 ↗
75. 10.1038/onc.2015.17910.1038/onc.2015.179 ↗
76. 10.1016/j.cmet.2011.06.00210.1016/j.cmet.2011.06.002 ↗
77. 10.1016/j.cell.2011.06.03410.1016/j.cell.2011.06.034 ↗
78. 10.1126/scisignal.200044610.1126/scisignal.2000446 ↗
79. 10.1038/sj.onc.120880210.1038/sj.onc.1208802 ↗
80. 10.1016/j.semcdb.2017.11.02610.1016/j.semcdb.2017.11.026 ↗
81. 10.1186/s40880-018-0301-410.1186/s40880-018-0301-4 ↗
82. 10.1016/j.cell.2017.07.02910.1016/j.cell.2017.07.029 ↗
83. 10.1101/cshperspect.a00678310.1101/cshperspect.a006783 ↗
84. 10.1016/j.cell.2017.10.03710.1016/j.cell.2017.10.037 ↗
85. 10.1097/MOL.000000000000050310.1097/MOL.0000000000000503 ↗
86. 10.1038/s41580-020-00315-910.1038/s41580-020-00315-9 ↗
87. 10.1016/j.ccell.2019.10.01110.1016/j.ccell.2019.10.011 ↗
88. 10.1016/j.molcel.2016.10.03910.1016/j.molcel.2016.10.039 ↗
89. 10.1038/nsmb.295910.1038/nsmb.2959 ↗
90. 10.1038/ncb359510.1038/ncb3595 ↗
91. 10.1186/s12943-022-01608-710.1186/s12943-022-01608-7 ↗
92. 10.1038/s41416-021-01600-w10.1038/s41416-021-01600-w ↗
93. 10.1101/gad.45570810.1101/gad.455708 ↗
94. 10.1016/j.redox.2022.10249310.1016/j.redox.2022.102493 ↗
95. 10.1038/s41467-019-13259-210.1038/s41467-019-13259-2 ↗
96. 10.1186/s12915-023-01597-z10.1186/s12915-023-01597-z ↗
97. 10.1186/s12943-019-1056-510.1186/s12943-019-1056-5 ↗
98. 10.1186/s12943-022-01620-x10.1186/s12943-022-01620-x ↗
99. 10.1101/gad.276022.11510.1101/gad.276022.115 ↗
100. 10.1038/s42255-020-0205-x10.1038/s42255-020-0205-x ↗